Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Invested Capital: 2016-2024

Historic Invested Capital for Akebia Therapeutics (AKBA) over the last 9 years, with Dec 2024 value amounting to -$10.5 million.

  • Akebia Therapeutics' Invested Capital rose 840.71% to $89.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.2 million, marking a year-over-year increase of 840.71%. This contributed to the annual value of -$10.5 million for FY2024, which is 355.96% down from last year.
  • According to the latest figures from FY2024, Akebia Therapeutics' Invested Capital is -$10.5 million, which was down 355.96% from $4.1 million recorded in FY2023.
  • Over the past 5 years, Akebia Therapeutics' Invested Capital peaked at $340.7 million during FY2020, and registered a low of -$10.5 million during FY2024.
  • For the 3-year period, Akebia Therapeutics' Invested Capital averaged around $21.6 million, with its median value being $4.1 million (2023).
  • Data for Akebia Therapeutics' Invested Capital shows a maximum YoY plummeted of 355.96% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Akebia Therapeutics' Invested Capital stood at $340.7 million in 2020, then crashed by 49.65% to $171.6 million in 2021, then tumbled by 58.43% to $71.3 million in 2022, then plummeted by 94.25% to $4.1 million in 2023, then tumbled by 355.96% to -$10.5 million in 2024.